Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.

Merindol N, Salem Fourati I, Brito RM, Grenier AJ, Charrier E, Cordeiro P, Caty M, Mezziani S, Malette B, Duval M, Alfieri C, Ovetchkine P, Le Deist F, Soudeyns H.

J Immunol. 2012 Nov 15;189(10):5016-28. doi: 10.4049/jimmunol.1201759. Epub 2012 Oct 3.

2.

Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.

Abate D, Cesaro S, Cofano S, Fiscon M, Saldan A, Varotto S, Mengoli C, Pillon M, Calore E, Biasolo MA, Cusinato R, Barzon L, Messina C, Carli M, Palù G.

Transplantation. 2012 Mar 15;93(5):536-42. doi: 10.1097/TP.0b013e31824215db.

PMID:
22314338
3.

Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.

Distler E, Schnürer E, Wagner E, von Auer C, Plachter B, Wehler D, Huber C, Kolbe K, Meyer RG, Herr W.

Biol Blood Marrow Transplant. 2008 Dec;14(12):1417-24. doi: 10.1016/j.bbmt.2008.09.004.

4.

Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.

Abate D, Saldan A, Fiscon M, Cofano S, Paciolla A, Furian L, Ekser B, Biasolo MA, Cusinato R, Mengoli C, Bonfante L, Rossi B, Rigotti P, Sgarabotto D, Barzon L, Palù G.

J Infect Dis. 2010 Aug 15;202(4):585-94. doi: 10.1086/654931.

PMID:
20594105
5.

Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.

Salem Fourati I, Grenier AJ, Jolette É, Merindol N, Ovetchkine P, Soudeyns H.

J Vis Exp. 2014 Jul 9;(89). doi: 10.3791/51643.

6.

Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.

Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L.

Bone Marrow Transplant. 2007 Mar;39(5):293-9. Epub 2007 Jan 29.

PMID:
17262060
8.

High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.

Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.

Transpl Immunol. 2009 Mar;20(4):238-42. doi: 10.1016/j.trim.2008.11.002. Epub 2008 Nov 24.

PMID:
19032982
9.

Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.

Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, Peracchi M, Furian L, Cusinato R, Bonfante L, Rossi B, Marchini F, Sgarabotto D, Rigotti P, Palù G.

J Clin Microbiol. 2013 Aug;51(8):2501-7. doi: 10.1128/JCM.00563-13. Epub 2013 May 15. Erratum in: J Clin Microbiol. 2014 Mar;52(3):1025.

10.

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.

Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D.

Bone Marrow Transplant. 2011 Nov;46(11):1437-43. doi: 10.1038/bmt.2010.330. Epub 2011 Jan 17.

PMID:
21243030
11.

Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.

Ma CK, Blyth E, Clancy L, Simms R, Burgess J, Brown R, Deo S, Micklethwaite KP, Gottlieb DJ.

Cytotherapy. 2015 Oct;17(10):1406-20. doi: 10.1016/j.jcyt.2015.07.005.

PMID:
26349000
12.

The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT.

Lenders K, Ogunjimi B, Beutels P, Hens N, Van Damme P, Berneman ZN, Van Tendeloo VF, Smits EL.

J Immunol Methods. 2010 May 31;357(1-2):51-4. doi: 10.1016/j.jim.2010.03.001. Epub 2010 Mar 6.

PMID:
20214906
13.

Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection.

Abate D, Fiscon M, Saldan A, Cofano S, Mengoli C, Sgarabotto D, d'Agostino C, Barzon L, Cusinato R, Toscano G, Feltrin G, Gambino A, Gerosa G, Palù G.

J Clin Microbiol. 2012 Jun;50(6):1974-80. doi: 10.1128/JCM.06406-11. Epub 2012 Mar 29.

14.

Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.

Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.

Haematologica. 2008 Feb;93(2):248-56. doi: 10.3324/haematol.11912.

15.

Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.

Prelog M, Schönlaub J, Jeller V, Almanzar G, Höfner K, Gruber S, Eiwegger T, Würzner R.

Vaccine. 2013 May 7;31(20):2420-6. doi: 10.1016/j.vaccine.2013.03.058. Epub 2013 Apr 10.

PMID:
23583889
16.

Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.

Abate D, Saldan A, Forner G, Tinto D, Bianchin A, Palù G.

J Virol Methods. 2014 Feb;196:157-62. doi: 10.1016/j.jviromet.2013.10.036. Epub 2013 Nov 8.

PMID:
24216234
17.

Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients.

Chiereghin A, Gabrielli L, Zanfi C, Petrisli E, Lauro A, Piccirilli G, Baccolini F, Dazzi A, Cescon M, Morelli MC, Pinna AD, Landini MP, Lazzarotto T.

Transplant Proc. 2010 Jan-Feb;42(1):69-73. doi: 10.1016/j.transproceed.2009.12.030.

PMID:
20172283
18.

Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.

Barron MA, Gao D, Springer KL, Patterson JA, Brunvand MW, McSweeney PA, Zeng C, Barón AE, Weinberg A.

Clin Infect Dis. 2009 Dec 15;49(12):1777-83. doi: 10.1086/648423.

PMID:
19911937
19.
20.

Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.

Ogunjimi B, Theeten H, Hens N, Beutels P.

J Med Virol. 2014 May;86(5):812-9. doi: 10.1002/jmv.23749. Epub 2013 Sep 13.

PMID:
24037981

Supplemental Content

Support Center